Preventive Oncology & Epidemiology (Jan 2023)

Cancer Research in 2030: A unique strategic planning process at a comprehensive cancer center

  • Erin M. Bank,
  • Eric J. Small,
  • Alan Ashworth,
  • Robert A. Hiatt

DOI
https://doi.org/10.1080/28322134.2023.2265563
Journal volume & issue
Vol. 1, no. 1

Abstract

Read online

Following the successful renewal of its Cancer Center Support Grant (CCSG), leadership of the UCSF Helen Diller Comprehensive Cancer Center (HDFCCC) began a strategic planning process. The motivation was to think about where cancer research was going in the future; and with this vision to define a general scientific direction, mission, and priorities. HDFCCC Leadership began discussions about a new strategic plan in early 2018. From these meetings, the theme of ‘Cancer Research in 2030’ arose: that is, what will cancer research look like in 2030? This forward-looking focus was intended to encourage creativity unconfined by a particular institutional structure or grant mechanism. Focusing on the science paved the way for an innovative, actionable, and motivating strategic planning process. Here, we describe the three-phase process, and the various groups involved across the HDFCCC and UCSF. We present the unique framework based on a cells-to-society model and an individual experience perspective, which led to the development of a logic model and ongoing implementation of tactics and tracking progress. We believe that sharing this process and its results will be of value to cancer centers and cancer researchers across the network of NCI comprehensive cancer centers, and cancer research centers in general.

Keywords